Literature DB >> 11470031

Perinatal Transmission of HIV: Recognition and Treatment Interventions.

Jaime Deville1, Yvonne Bryson.   

Abstract

Great strides have been made in the fight against vertical transmission of HIV-1. Improved understanding of mechanisms and timing of transmission of HIV-1 from mother to child have led to the development of effective intervention strategies that have reduced transmission rates to unprecedented low levels, below 2% in developed countries. New reports using shortened, more affordable courses of antiretrovirals prenatally or at the time of delivery have also shown a significant reduction in transmission, over 50% in studies conducted in the developing world. These advances, combined with ongoing studies using simplified effective treatment regimens, have made possible the potential to significantly reduce perinatal transmission worldwide. Future challenges include reduction of breast feeding transmission and the development of an effective HIV-1 vaccine to produce long-lasting protection.

Entities:  

Year:  2001        PMID: 11470031     DOI: 10.1007/s11908-001-0080-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  48 in total

1.  Short courses of zidovudine and perinatal transmission of HIV.

Authors:  N Shaffer; M Bulterys; R J Simonds
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

2.  Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.

Authors:  J Pitt; D Brambilla; P Reichelderfer; A Landay; K McIntosh; D Burns; G V Hillyer; H Mendez; M G Fowler
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

3.  Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Italian Multicentre Study.

Authors: 
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

4.  Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-01-30

5.  Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire.

Authors:  R W Ryder; W Nsa; S E Hassig; F Behets; M Rayfield; B Ekungola; A M Nelson; U Mulenda; H Francis; K Mwandagalirwa
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

6.  Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes.

Authors:  C H Contag; A Ehrnst; J Duda; A B Bohlin; S Lindgren; G H Learn; J I Mullins
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Risk of human immunodeficiency virus type 1 transmission through breastfeeding.

Authors:  D T Dunn; M L Newell; A E Ades; C S Peckham
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

8.  Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.

Authors:  R E Dickover; M Dillon; K M Leung; P Krogstad; S Plaeger; S Kwok; C Christopherson; A Deveikis; M Keller; E R Stiehm; Y J Bryson
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

9.  Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  N Shaffer; A Roongpisuthipong; W Siriwasin; T Chotpitayasunondh; S Chearskul; N L Young; B Parekh; P A Mock; C Bhadrakom; P Chinayon; M L Kalish; S K Phillips; T C Granade; S Subbarao; B G Weniger; T D Mastro
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

10.  Prevalence and incidence of vertically acquired HIV infection in the United States.

Authors:  S F Davis; R H Byers; M L Lindegren; M B Caldwell; J M Karon; M Gwinn
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

View more
  2 in total

1.  Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro.

Authors:  Azadeh Farzin; Pamela Boyer; Bonnie Ank; Karin Nielsen-Saines; Yvonne Bryson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-07       Impact factor: 2.205

2.  Modeling vertical transmission of HIV: imperfect vaccines can be of benefit.

Authors:  Myung Shin K Sim; William G Cumberland; Naihua Duan; Yvonne J Bryson
Journal:  Vaccine       Date:  2009-10-01       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.